Professional Documents
Culture Documents
E-mail: lwinntech@gmail.com.
Summary
Based on this theory, there are two types of organisms or microbes for a
specific opsonising host-organism: those for which interactions could not be
established (type I) and those for which interactions could be productively
established (type II). Type I organism which is unable to establish interaction,
will thus go unnoticed because it is without host-specific opsonin receptors and is
unable to directly express receptors specific for the host. Type I organisms for a
human host-organism are those multiple microbes that fail to establish interaction
with us but they will interact (invade, infect, colonize, adhere, etc.) with other
species. Type II organisms, which will productively establish interactions with a
given host-organism are either opsonized by the host opsonins or are able to
directly express receptors for the specific host cells (Figure 1). Depending on
their ability to disseminate and overgrow inside the host, type II organisms can
either be beneficial or deleterious. The latter affect the energy homeostasis of
the host cells and tissues and produce damage and eventually disease. Factors
such as the nutritional or the immune state of the host will determine if a
beneficial organism can be transformed into a deleterious organism. The
damage-response framework theory explains the possible outcomes, once the
initial interactions are established (Casadevall and Pirofski 2003). Antibodies—
and in particular, natural antibodies—play an instrumental role as the main
opsonins in the organisms’ interactions, but so also do other abundant and
ubiquitous glycoproteins and glycolipids. The interactions that happen between
organisms and the immune system follow this theory; however, the type of
receptors and antigens involved in these types of interactions are mainly—but
not exclusively—proteins and peptides. In cell membranes, the lipid raft
platforms are the location where the first events involved in recognition and
interactions are inititated including the vigilance that triggers signalling cascades.
2007)
Streptococcus agalactiae FbsA (fibronectin receptor) (Schubert,
enhances adherence to human Zakikhany et al.
epithelial cells and to human 2004;
brain microvascular endothelial Tenenbaum,
cells Bloier et al. 2005)
Streptococcus group A Fibronectin binding gene prtF2 is (Gorton, Norton
associated with enhanced et al. 2005)
bacterial internalization
Vibrio vulnificus Outer membrane OmpU has a (Goo, Lee et al.
role in microbe pathogenesis 2006)
Yersinia YadA recognition of fibronectin is (Heise and
pseudotuberculosis determinant of their ability to Dersch 2006)
infect human cells
Glycosaminoglicans
Streptococcus Attachment to nasopharyngeal (Tonnaer,
pneumoniae epithelial cells mediated by Hafmans et al.
glycosaminoglycans 2006)
Streptococcus uberis The adherence and (Almeida, Luther
internalization of the bovine et al. 2003)
mastitis-associated bacteria is
enhanced by host
glycosaminoglicans
Lactoferrin
HIV-1 Together with natural antibodies (Saidi, Eslaphazir
enhances adsorption on et al. 2006)
epithelial cells and dendritic cells
Mucin
Clostridium difficile Flagellar proteins FliC and FliD (Tasteyre, Barc
play a role in adherence and gut et al. 2001)
colonization in mice
Group A Streptococci Mucin and human pharyngeal (Ryan, Pancholi
cells are recognized through et al. 2001)
receptors containing sialic acid
Helicobacter pylori Co-localizes with MUC5AC in (Van den Brink,
human stomach Tytgat et al.
2000)
Lactobacillus johnsonii Bacterial surface-associated (Granato,
elongation factor Tu mediates Bergonzelli et al.
attachment to human intestinal 2004)
References
Kroese, F. G. M., R. de Waard, et al. (1996). "B-1 cells and their reactivity with
the murine intestinal microflora." Seminars in Immunology 8(1): 11-18.
Landers, J. J., Z. Cao, et al. (2002). "Prevention of influenza pneumonitis by
sialic Acid-conjugated dendritic polymers." The Journal of Infectious
Diseases 186(9): 1222-30.
Lauc, G. and M. Heffer-Lauc (2006). "Shedding and uptake of gangliosides and
glycosylphosphatidylinositol-anchored proteins." Biochimica et
Biophysica Acta (BBA) - General Subjects 1760(4): 584-602.
Leroy-Dudal, J., H. Gagniere, et al. (2004). "Role of [alpha]v[beta]5 integrins
and vitronectin in Pseudomonas aeruginosa PAK interaction with A549
respiratory cells." Microbes and Infection 6(10): 875-881.
Li, H., A. Nowak-Wegrzyn, et al. (2006). "Transcytosis of IgE-Antigen
Complexes by CD23a in Human Intestinal Epithelial Cells and Its Role in
Food Allergy." Gastroenterology 131(1): 47-58.
Liu, D., C. C. Cramer, et al. (2005). "N-Linked Glycosylation at Asn3 and the
Positively Charged Residues within the Amino-Terminal Domain of the
C1 Inhibitor Are Required for Interaction of the C1 Inhibitor with
Salmonella enterica Serovar Typhimurium Lipopolysaccharide and Lipid
A." Infection and Immunity 73(8): 4478-4487.
Macpherson, A. J., L. Hunziker, et al. (2001). "IgA responses in the intestinal
mucosa against pathogenic and non-pathogenic microorganisms."
Microbes and Infection 3(12): 1021-1035.
Macpherson, A. J. and T. Uhr (2004). "Induction of Protective IgA by Intestinal
Dendritic Cells Carrying Commensal Bacteria." Science 303(5664):
1662-1665.
Magnusson, K. K. E. and I. I. Stjernström (1982). "Mucosal barrier mechanisms.
Interplay between secretory IgA (SIgA), IgG and mucins on the surface
properties and association of salmonellae with intestine and
granulocytes." Immunology 45(2): 239-48.
Manes, S., G. del Real, et al. (2003). "Pathogens: raft hijackers." Nat Rev
Immunol 3(7): 557-568.
Martin, P. T. and H. H. Freeze (2003). "Glycobiology of neuromuscular
disorders." Glycobiology 13(8): 67R-75.
McCool, T. L. and J. N. Weiser (2004). "Limited Role of Antibody in Clearance
of Streptococcus pneumoniae in a Murine Model of Colonization."
Infection and Immunity 72(10): 5807-5813.
Mentis, A., C. C. Blackwell, et al. (1991). "ABO blood group, secretor status and
detection of Helicobacter pylori among patients with gastric or duodenal
ulcers." Epidemiology and Infectology 106: 221-229.
Merrell, D. S., S. M. Butler, et al. (2002). "Host-induced epidemic spread of the
cholera bacterium." Nature 417(6889): 642-645.
Mestecky, J., M. W. Russell, et al. (1999). "Intestinal IgA: novel views on its
function in the defence of the largest mucosal surface." Gut 44(1): 2-5.
Miller, B. S. and H. H. Freeze (2003). "New Disorders in Carbohydrate
Metabolism: Congenital Disorders of Glycosylation and Their Impact on
the Endocrine System." Reviews in Endocrine & Metabolic Disorders
4(1): 103-113.